Merck known as MSD outside of the United States and Canada, announced that the Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its primary endpoint of progression-free survival (PFS) for the treatment of patients with platinum-resistant recurrent ovarian cancer whose tumors expressed PD-L1 ...

Rockwell Automation, Inc., the world's largest company dedicated to industrial automation and digital transformation, announced the launch of FactoryTalk® PharmaSuite® 12.00. The latest release of its manufacturing execution system (MES) is designed to support the unique needs of regulated ...

Bruker Corporation announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving animals. It leverages advanced two-photon fluorescence microscopy technology to enable high-resolution imaging ...

AptarGroup, Inc. a global leader in drug and consumer product dosing, dispensing and protection technologies, announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform.

The platform was developed by Aptar’s drug services company, Nanopharm. If validated, ...

Bruker Corporation announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays.

...

Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, announces the positive results from the SPEED1 survey, showcasing the impact of the iPUMP® connected assistant on adherence to Stallergenes Greer’s sublingual liquid immunotherapy (SLIT).

The ...